Skip to content

Smart Glasses for Radial Arterial Catheterization In Adult Patients: A Randomized Clinical Trial

Wireless Smart Glasses for Radial Arterial Catheterization In Adult Patients: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102026
Enrollment
Unknown
Registered
2025-05-07
Start date
2025-05-07
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Interventions

Sponsors

Hebei Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.The patient or family member signs the informed consent form; 2.Aged 18–79 years; 3.Gender: Any; 4.Classified as ASA I–III.

Exclusion criteria

Exclusion criteria: 1.Recent radial artery puncture, wound, infection, hematoma at the arterial cannulation site. 2.Peripheral vascular disease, abnormal coagulation function, insufficient collateral circulation (positive Allen test). 3.Unstable vital signs, severe arrhythmia, shock.

Design outcomes

Primary

MeasureTime frame
Catheter insertion time;

Secondary

MeasureTime frame
Needle redirection frequency;Overall complication rate;The difficulty level;Repositioning frequency of the ultrasound probe;Operator’s satisfaction;Total number of attempts;Ultrasound positioning time;Radial artery diameter and depth;Head rotation frequency;The first-pass success of radial artery puncture;The first-attempt success of radial artery puncture;Overall success rate;Operators’ ergonomic score was recorded;

Countries

China

Contacts

Public ContactWudong Zhuang

Hebei Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine

laozhuang1015@163.com+86 189 3278 9870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026